Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: A multicenter retrospective cohort study

Abstract

Abstract Background Colon perforation caused by colorectal cancer (CRC) is a fatal condition requiring emergency intervention. For patients with metastatic lesions, surgeons face difficult decisions regarding whether to resect the primary and metastatic lesions. Moreover, there is currently no established treatment strategy for these patients. This study aimed to investigate the clinical practice and long-term outcomes of patients with metastatic CRC diagnosed with the onset of colon perforation. Methods We performed a population-based multicenter cohort study. Consecutive patients diagnosed with stage IV CRC between 2008 and 2015 at all designated cancer hospitals in Fukushima Prefecture, Japan, were enrolled in this study. We evaluated the impact of colon perforation on the survival outcomes of patients with metastatic CRC. The main outcome was the adjusted hazard ratio (aHR) of perforation for overall survival (OS). Survival time and HRs were estimated using Kaplan‒Meier and Cox proportional regression analyses. Results A total of 1258 patients were enrolled (perforation: n = 46; non-perforation: n = 1212). The median follow-up time was 17.0 months (interquartile range: 6.0–32.0), and 927 patients died during the study period. The median OS for the perforation and non-perforation groups was 19.0 and 20.0 months, respectively (p = 0.96). Moreover, perforation was not an independent prognostic factor (aHR: 0.99; 95% confidence interval: 0.61–1.28). Conclusions In metastatic CRC, perforation is not necessarily a poor prognostic factor. Patients with perforation who undergo acute phase treatment and prompt initiation of systemic chemotherapy might be expected to have a survival time similar to that of patients with non-perforated colon.